Literature DB >> 8146134

Evolution of drug-resistant tuberculosis: a tale of two species.

M D Iseman1.   

Abstract

The history of the disease tuberculosis is briefly discussed. Now human societal failures have potentiated the evolution of drug-resistant strains of the tubercle bacillus in the United States and around the world. Until recently, this evolutionary change largely posed a threat to the health and survival of the individual in whom inadequate therapy promoted the drug resistance. However, the human immunodeficiency virus epidemic threatens to promote wholesale transmission of multidrug-resistant tuberculosis with the potential for immense morbidity and mortality. Reinforced treatment and control programs for tuberculosis are vital.

Entities:  

Mesh:

Year:  1994        PMID: 8146134      PMCID: PMC43383          DOI: 10.1073/pnas.91.7.2428

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  14 in total

1.  Primary drug resistance in tuberculosis. A review. I.

Authors:  G L HOBBY
Journal:  Am Rev Respir Dis       Date:  1962-12

2.  Some observations on the pathogenicity of isoniazid-resistant variants of tubercle bacilli.

Authors:  G MIDDLEBROOK; M L COHN
Journal:  Science       Date:  1953-09-11       Impact factor: 47.728

Review 3.  The increasing prevalence of resistance to antituberculosis chemotherapeutic agents: implications for global tuberculosis control.

Authors:  M D Iseman; J A Sbarbaro
Journal:  Curr Clin Top Infect Dis       Date:  1992

4.  Compliance in developed nations.

Authors:  L B Reichman
Journal:  Tubercle       Date:  1987-06

5.  Microbiology of tubercle bacilli.

Authors:  L G Wayne
Journal:  Am Rev Respir Dis       Date:  1982-03

6.  Some observations on the genetics of isoniazid resistance in the tubercle bacilli.

Authors:  H L David; C M Newman
Journal:  Am Rev Respir Dis       Date:  1971-10

7.  A continuing survey of primary drug resistance in tuberculosis, 1961 to 1968. A U.S. Public Health Service cooperative study.

Authors:  B Doster; G J Caras; D E Snider
Journal:  Am Rev Respir Dis       Date:  1976-04

8.  Drug resistance among previously treated tuberculosis patients, a brief report.

Authors:  H D Costello; G J Caras; D E Snider
Journal:  Am Rev Respir Dis       Date:  1980-02

9.  The emergence of drug-resistant tuberculosis in New York City.

Authors:  T R Frieden; T Sterling; A Pablos-Mendez; J O Kilburn; G M Cauthen; S W Dooley
Journal:  N Engl J Med       Date:  1993-02-25       Impact factor: 91.245

10.  An outbreak of multidrug-resistant tuberculosis among hospitalized patients with the acquired immunodeficiency syndrome.

Authors:  B R Edlin; J I Tokars; M H Grieco; J T Crawford; J Williams; E M Sordillo; K R Ong; J O Kilburn; S W Dooley; K G Castro
Journal:  N Engl J Med       Date:  1992-06-04       Impact factor: 91.245

View more
  14 in total

1.  Altered permeability and beta-lactam resistance in a mutant of Mycobacterium smegmatis.

Authors:  S Mukhopadhyay; P Chakrabarti
Journal:  Antimicrob Agents Chemother       Date:  1997-08       Impact factor: 5.191

2.  Comparative antimycobacterial activities of rifampin, rifapentine, and KRM-1648 against a collection of rifampin-resistant Mycobacterium tuberculosis isolates with known rpoB mutations.

Authors:  S L Moghazeh; X Pan; T Arain; C K Stover; J M Musser; B N Kreiswirth
Journal:  Antimicrob Agents Chemother       Date:  1996-11       Impact factor: 5.191

3.  Biochemical characterization of the 49 kDa penicillin-binding protein of Mycobacterium smegmatis.

Authors:  T Mukherjee; D Basu; S Mahapatra; C Goffin; J van Beeumen; J Basu
Journal:  Biochem J       Date:  1996-11-15       Impact factor: 3.857

4.  Surgery for patients with drug-resistant tuberculosis: report of 121 cases receiving community-based treatment in Lima, Peru.

Authors:  Jose G Somocurcio; Alfredo Sotomayor; Sonya Shin; Silvia Portilla; Maria Valcarcel; Dalia Guerra; Jennifer Furin
Journal:  Thorax       Date:  2006-08-23       Impact factor: 9.139

5.  A common mechanism for the biosynthesis of methoxy and cyclopropyl mycolic acids in Mycobacterium tuberculosis.

Authors:  Y Yuan; C E Barry
Journal:  Proc Natl Acad Sci U S A       Date:  1996-11-12       Impact factor: 11.205

6.  Predictive models for anti-tubercular molecules using machine learning on high-throughput biological screening datasets.

Authors:  Vinita Periwal; Jinuraj K Rajappan; Abdul Uc Jaleel; Vinod Scaria
Journal:  BMC Res Notes       Date:  2011-11-18

Review 7.  Mycobacterium tuberculosis pathogenesis and molecular determinants of virulence.

Authors:  Issar Smith
Journal:  Clin Microbiol Rev       Date:  2003-07       Impact factor: 26.132

8.  Transposon-5 mutagenesis transforms Corynebacterium matruchotii to synthesize novel hybrid fatty acids that functionally replace corynomycolic acid.

Authors:  Kuni Takayama; Barry Hayes; Matha M Vestling; Randall J Massey
Journal:  Biochem J       Date:  2003-07-15       Impact factor: 3.857

9.  Can penicillins and other beta-lactam antibiotics be used to treat tuberculosis?

Authors:  H F Chambers; D Moreau; D Yajko; C Miick; C Wagner; C Hackbarth; S Kocagöz; E Rosenberg; W K Hadley; H Nikaido
Journal:  Antimicrob Agents Chemother       Date:  1995-12       Impact factor: 5.191

10.  In vivo validation of the mutant selection window hypothesis with moxifloxacin in a murine model of tuberculosis.

Authors:  Deepak Almeida; Eric Nuermberger; Sandeep Tyagi; William R Bishai; Jacques Grosset
Journal:  Antimicrob Agents Chemother       Date:  2007-10-15       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.